{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:02:12Z","timestamp":1777471332795,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.pbb.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T04:16:42Z","timestamp":1295065002000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice"],"prefix":"10.1016","volume":"98","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Misiuta-Krzesinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Florek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Tutka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislaw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.01.002_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1535-7597.2004.04501.x","article-title":"Endocannabinoids and their implications for epilepsy","volume":"4","author":"Alger","year":"2004","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.pbb.2011.01.002_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2009.01.003","article-title":"Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice","volume":"84","author":"Bahremand","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pbb.2011.01.002_bb0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.105.100354","article-title":"Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus","volume":"317","author":"Blair","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.01.002_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00422641","article-title":"9-Tetrahydrocannabinol effect on audiogenic seizure susceptibility","volume":"29","author":"Boggan","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l'action tranquilisante: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp (Basel)"},{"key":"10.1016\/j.pbb.2011.01.002_bb0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0014-4886(73)90088-5","article-title":"Acute antiepileptic effects of 9-tetrahydrocannabinol in rats with kindled seizures","volume":"40","author":"Corcoran","year":"1973","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0035","first-page":"154","article-title":"The anticonvulsant activity of cannabinoids in seizure sensitive gerbils","volume":"18","author":"Cox","year":"1975","journal-title":"Proc West Pharmacol Soc"},{"issue":"Suppl. 11","key":"10.1016\/j.pbb.2011.01.002_bb0040","first-page":"366","article-title":"Effect of ACEA \u2014 a highly selective cannabinoid CB1 receptor agonist on the protective action of clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced clonic seizure model","volume":"50","author":"Czuczwar","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0045","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2006.11.030","article-title":"Endocannabinoids block status epilepticus in cultured hippocampal neurons","volume":"558","author":"Deshpande","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(75)90268-9","article-title":"Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine","volume":"31","author":"Dwivedi","year":"1975","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0060","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.neuroscience.2007.01.065","article-title":"Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy","volume":"146","author":"Falenski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.01.002_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2009.01.036","article-title":"Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus","volume":"1262","author":"Falenski","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.01.002_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-4886(73)90276-8","article-title":"Effects of tetrahydrocannabinol on hippocampal evoked afterdischarges in cats","volume":"41","author":"Feeney","year":"1973","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuropharm.2007.08.005","article-title":"Ultra-low dose cannabinoid antagonist AM251 exchanges cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice","volume":"53","author":"Gholizadeh","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.01.002_bb0080","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1211\/0022357011777891","article-title":"Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms","volume":"53","author":"Hayase","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0085","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.107.120147","article-title":"Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage","volume":"322","author":"Karanian","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.01.002_bb0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0024-3205(74)90009-5","article-title":"Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids","volume":"15","author":"Karler","year":"1974","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.01.002_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2220\/biomedres.26.241","article-title":"Cannabinoid suppressed bicuculline-induced convulsion without respiratory depression in the brainstem-spinal cord preparation from newborn rats","volume":"26","author":"Koda","year":"2005","journal-title":"Biomed Res"},{"key":"10.1016\/j.pbb.2011.01.002_bb0100","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1528-1167.2009.02098.x","article-title":"The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats","volume":"50","author":"Kozan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.01.002_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pbb.2011.01.002_bb0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(03)00081-9","article-title":"Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice","volume":"75","author":"Luszczki","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","article-title":"Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice","volume":"28","author":"Luszczki","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.01.002_bb0125","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"Luszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.01.002_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.07.037","article-title":"Arachidonyl-2\u2032-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model","volume":"547","author":"Luszczki","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"Luszczki","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2009.09.005","article-title":"Effect of arachidonyl-2\u2032-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"34","author":"Luszczki","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.01.002_bb0150","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2004.07.007","article-title":"On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures","volume":"68","author":"Lutz","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0091-3057(74)90057-4","article-title":"Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats","volume":"2","author":"McCaughran","year":"1974","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.01.002_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1528-1157.1974.tb04947.x","article-title":"Delta9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio","volume":"15","author":"Meldrum","year":"1974","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0165","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav Toxicol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2011.01.002_bb0175","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00702-008-0076-x","article-title":"Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice","volume":"115","author":"Naderi","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2011.01.002_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2009.07.014","article-title":"Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat","volume":"462","author":"Rizzo","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.01.002_bb0185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1528-1167.2009.02334.x","article-title":"Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy","volume":"51","author":"Romigi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.01.002_bb0195","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.0013-9580.2004.16604.x","article-title":"Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid","volume":"45","author":"Sheerin","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2011.01.002_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(97)01195-5","article-title":"The cannabinoid agonist WIN 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons","volume":"783","author":"Shen","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.01.002_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(24)23149-7","article-title":"Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"Shen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0210","first-page":"680","article-title":"Cannabinoids as potential anti-epileptic drugs","volume":"6","author":"Smith","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2011.01.002_bb0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/seiz.2002.0711","article-title":"Seizure freedom with more than one antiepileptic drug","volume":"11","author":"Stephen","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.pbb.2011.01.002_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0014-2999(75)90087-4","article-title":"Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil","volume":"31","author":"Ten Ham","year":"1975","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0225","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.01.002_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-4886(73)90048-4","article-title":"Antiepileptic properties of 9-tetrahydrocannabinol","volume":"39","author":"Wada","year":"1973","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.01.002_bb0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.01.002_bb0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1734-1140(09)70128-8","article-title":"Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice","volume":"61","author":"Zadrozniak","year":"2009","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:29:49Z","timestamp":1758774589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0091305711000074"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.01.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2011.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}